Literature DB >> 9180609

Risk factors in dengue shock syndrome.

S Thein1, M M Aung, T N Shwe, M Aye, A Zaw, K Aye, K M Aye, J Aaskov.   

Abstract

Despite a growing body of evidence predominantly, but not exclusively, from Thailand suggesting that the risk of developing dengue shock syndrome (DSS) is greatest following an anamnestic dengue infection, particularly if the most recent infection was with dengue 2 virus, there continues to be debate about the justification for these claims. This report describes a five-year, prospective study in two townships (suburbs) in Yangon (Rangoon) Myanmar (Burma) in which attempts were made to confirm the data from an earlier prospective study in Thailand and to address some of the criticism of earlier studies. This investigation found the incidence of anamnestic dengue infections in DSS patients to be significantly higher than in the community from which they were drawn and a significantly higher risk of developing DSS following an anamnestic infection (particularly with dengue 2 virus) than following a primary infection with any serotype.

Entities:  

Mesh:

Year:  1997        PMID: 9180609     DOI: 10.4269/ajtmh.1997.56.566

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  126 in total

1.  Transmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveys.

Authors:  N M Ferguson; C A Donnelly; R M Anderson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

2.  B-cell responses during primary and secondary dengue virus infections in humans.

Authors:  Anuja Mathew; Kim West; Siripen Kalayanarooj; Robert V Gibbons; Anon Srikiatkhachorn; Sharone Green; Daniel Libraty; Smita Jaiswal; Alan L Rothman
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

Review 3.  Dengue: an escalating problem.

Authors:  Robert V Gibbons; David W Vaughn
Journal:  BMJ       Date:  2002-06-29

Review 4.  Dengue: defining protective versus pathologic immunity.

Authors:  Alan L Rothman
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

5.  Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections.

Authors:  Vanda Akico Ueda Fick de Souza; Silvana Fernandes; Evaldo Stanislau Araújo; Adriana Fumie Tateno; Olímpia M N P F Oliveira; Renato Reis Oliveira; Cláudio Sérgio Pannuti
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

6.  Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells.

Authors:  Simona Zompi; Brian H Santich; P Robert Beatty; Eva Harris
Journal:  J Immunol       Date:  2011-11-30       Impact factor: 5.422

7.  Validation of probability equation and decision tree in predicting subsequent dengue hemorrhagic fever in adult dengue inpatients in Singapore.

Authors:  Tun L Thein; Yee-Sin Leo; Vernon J Lee; Yan Sun; David C Lye
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

8.  Factors associated with dengue mortality in Latin America and the Caribbean, 1995-2009: an ecological study.

Authors:  Fredi Alexander Díaz-Quijano; Eliseu Alves Waldman
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

9.  Homology of complete genome sequences for dengue virus type-1, from dengue-fever- and dengue-haemorrhagic-fever-associated epidemics in Hawaii and French Polynesia.

Authors:  A Imrie; C Roche; Z Zhao; S Bennett; M Laille; P Effler; V-M Cao-Lormeau
Journal:  Ann Trop Med Parasitol       Date:  2010-04

10.  CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions.

Authors:  Georgette L Suidan; Jonathan W Dickerson; Yi Chen; Jeremiah R McDole; Pulak Tripathi; Istvan Pirko; Kim B Seroogy; Aaron J Johnson
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.